Variant report

Variant	nsv482197
Chromosome Location	chr16:75237995-75241072
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:53)
CpG islands
(count:183)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:53 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CHD2	chr16:75240976-75240986	HepG2	liver:	n/a	n/a
2	CTCF	chr16:75239214-75239309	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr16:75238923-75239001	GM13976	blood:	n/a	n/a
4	EBF1	chr16:75240514-75240894	GM12878	blood:	n/a	chr16:75240725-75240736
5	EBF1	chr16:75240353-75240887	GM12878	blood:	n/a	chr16:75240725-75240736
6	ELF1	chr16:75240431-75240982	GM12878	blood:	n/a	n/a
7	MAZ	chr16:75240656-75240891	GM12878	blood:	n/a	n/a
8	MTA3	chr16:75240310-75240643	GM12878	blood:	n/a	n/a
9	MYC	chr16:75239793-75239809	MCF-7	breast:	n/a	n/a
10	MYC	chr16:75238867-75238968	H1-hESC	embryonic stem cell:	n/a	n/a
11	MYC	chr16:75239784-75239791	MCF-7	breast:	n/a	n/a
12	MYC	chr16:75239773-75239778	MCF-7	breast:	n/a	n/a
13	MYC	chr16:75238792-75238857	H1-hESC	embryonic stem cell:	n/a	n/a
14	MYC	chr16:75240997-75241160	H1-hESC	embryonic stem cell:	n/a	n/a
15	NR3C1	chr16:75239093-75239472	A549	lung:	n/a	n/a
16	NR3C1	chr16:75239114-75239467	A549	lung:	n/a	n/a
17	POLR2A	chr16:75238886-75238938	HUVEC	blood vessel:	n/a	n/a
18	POLR2A	chr16:75239173-75239301	K562	blood:	n/a	n/a
19	POLR2A	chr16:75238574-75238889	A549	lung:	n/a	n/a
20	POLR2A	chr16:75238747-75238759	MCF-7	breast:	n/a	n/a
21	POLR2A	chr16:75238596-75238705	MCF-7	breast:	n/a	n/a
22	POLR2A	chr16:75238650-75238820	MCF-7	breast:	n/a	n/a
23	POLR2A	chr16:75240626-75240653	HUVEC	blood vessel:	n/a	n/a
24	POLR2A	chr16:75239000-75239144	HUVEC	blood vessel:	n/a	n/a
25	POLR2A	chr16:75240186-75240559	Hela-S3	cervix:	n/a	n/a
26	POLR2A	chr16:75238595-75238636	MCF-7	breast:	n/a	n/a
27	POLR2A	chr16:75239712-75239831	ProgFib	skin:	n/a	n/a
28	POLR2A	chr16:75239572-75239679	MCF-7	breast:	n/a	n/a
29	POLR2A	chr16:75238555-75238833	H1-hESC	embryonic stem cell:	n/a	n/a
30	POLR2A	chr16:75238756-75238770	Gliobla	brain:	n/a	n/a
31	POLR2A	chr16:75238600-75238765	HUVEC	blood vessel:	n/a	n/a
32	POLR2A	chr16:75239415-75239457	HUVEC	blood vessel:	n/a	n/a
33	POLR2A	chr16:75238976-75239057	ProgFib	skin:	n/a	n/a
34	POLR2A	chr16:75239170-75239379	MCF-7	breast:	n/a	n/a
35	POLR2A	chr16:75239181-75239417	ProgFib	skin:	n/a	n/a
36	POLR2A	chr16:75238652-75238671	ProgFib	skin:	n/a	n/a
37	POLR2A	chr16:75238735-75238745	MCF-7	breast:	n/a	n/a
38	POLR2A	chr16:75240548-75240581	HUVEC	blood vessel:	n/a	n/a
39	POLR2A	chr16:75238694-75238730	Hela-S3	cervix:	n/a	n/a
40	POLR2A	chr16:75238539-75238799	H1-hESC	embryonic stem cell:	n/a	n/a
41	POLR2A	chr16:75240187-75241287	HepG2	liver:	n/a	n/a
42	POLR2A	chr16:75239174-75239407	HUVEC	blood vessel:	n/a	n/a
43	POLR2A	chr16:75238731-75238750	Gliobla	brain:	n/a	n/a
44	POLR2A	chr16:75238675-75238717	ProgFib	skin:	n/a	n/a
45	POLR2A	chr16:75238940-75238974	ProgFib	skin:	n/a	n/a
46	POLR2A	chr16:75238836-75238854	H1-hESC	embryonic stem cell:	n/a	n/a
47	POLR2A	chr16:75238779-75238936	ProgFib	skin:	n/a	n/a
48	RAD21	chr16:75237616-75238086	H1-hESC	embryonic stem cell:	n/a	n/a
49	RELA	chr16:75240485-75240849	GM19099	blood:	n/a	n/a
50	RELA	chr16:75240410-75240924	GM12891	blood:	n/a	n/a

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:75241064-75241114	Jurkat	blood:	n/a
2	chr16:75240536-75240586	BE2_C	brain:	n/a
3	chr16:75241064-75241114	T-47D	breast:	n/a
4	chr16:75241064-75241114	PANC-1	pancreas:	n/a
5	chr16:75239551-75239601	MCF-7	breast:	n/a
6	chr16:75241064-75241114	AG10803	skin:	n/a
7	chr16:75239551-75239601	HCF	heart:	n/a
8	chr16:75239551-75239601	HEK293	kidney:	embryo
9	chr16:75240536-75240586	BJ	skin:	n/a
10	chr16:75239551-75239601	GM12878	blood:	n/a
11	chr16:75241064-75241114	RPTEC	kidney:	n/a
12	chr16:75240536-75240586	Hela-S3	cervix:	n/a
13	chr16:75240536-75240586	PFSK-1	brain:	n/a
14	chr16:75239551-75239601	AoSMC	blood vessel:	n/a
15	chr16:75239551-75239601	GM19239	blood:	n/a
16	chr16:75241064-75241114	HNPCEpiC	eye:	n/a
17	chr16:75239551-75239601	PrEC	prostate:	n/a
18	chr16:75240536-75240586	SK-N-SH	brain:	n/a
19	chr16:75241064-75241114	HepG2	liver:	n/a
20	chr16:75240536-75240586	A549	lung:	n/a
21	chr16:75239551-75239601	HNPCEpiC	eye:	n/a
22	chr16:75239551-75239601	HIPEpiC	eye:	n/a
23	chr16:75241064-75241114	NT2-D1	testis:	n/a
24	chr16:75241064-75241114	AoSMC	blood vessel:	n/a
25	chr16:75239551-75239601	Hela-S3	cervix:	n/a
26	chr16:75239551-75239601	H1-hESC	embryonic stem cell:	embryo
27	chr16:75240536-75240586	IMR90	lung:	fetal
28	chr16:75240536-75240586	HNPCEpiC	eye:	n/a
29	chr16:75239551-75239601	HCT-116	colon:	n/a
30	chr16:75240536-75240586	GM19239	blood:	n/a
31	chr16:75240536-75240586	AG09319	gingival:	n/a
32	chr16:75240536-75240586	GM12891	blood:	n/a
33	chr16:75240536-75240586	GM12892	blood:	n/a
34	chr16:75240536-75240586	GM06990	blood:	n/a
35	chr16:75241064-75241114	GM12878	blood:	n/a
36	chr16:75239551-75239601	ProgFib	skin:	n/a
37	chr16:75239551-75239601	PFSK-1	brain:	n/a
38	chr16:75239551-75239601	NT2-D1	testis:	n/a
39	chr16:75239551-75239601	SAEC	small airway:	n/a
40	chr16:75240536-75240586	NH-A	brain:	n/a
41	chr16:75239551-75239601	SKMC	muscle:	n/a
42	chr16:75241064-75241114	H1-hESC	embryonic stem cell:	embryo
43	chr16:75241064-75241114	NHDF-neo	bronchial:	n/a
44	chr16:75241064-75241114	HMEC	breast:	n/a
45	chr16:75240536-75240586	K562	blood:	n/a
46	chr16:75240536-75240586	GM12878	blood:	n/a
47	chr16:75241064-75241114	NB4	blood:	n/a
48	chr16:75239551-75239601	Hepatocyte	liver:	n/a
49	chr16:75239551-75239601	HepG2	liver:	n/a
50	chr16:75240536-75240586	HAEpiC	amniotic membrane:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr16:75239080..75244320-chr16:75282735..75286046,5	K562	blood:
2	chr16:75239816..75243837-chr16:75256696..75260507,7	MCF-7	breast:

No data

Variant related genes	Relation type
CTRB2	TF binding region
CTRB2	CpG island
ENSG00000240338	chromatin interactions
ENSG00000050820	chromatin interactions

Extended variants
information (count: 174 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:174 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs373214805	chr16:75238009-75238010	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs376408035	chr16:75238010-75238011	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs369741106	chr16:75238013-75238014	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs373513883	chr16:75238015-75238016	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs370422301	chr16:75238040-75238041	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs201246675	chr16:75238045-75238046	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs570589360	chr16:75238048-75238049	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs373944434	chr16:75238052-75238053	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs200581285	chr16:75238055-75238056	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs34824152	chr16:75238062-75238063	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs1049303	chr16:75238068-75238069	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs200309186	chr16:75238076-75238077	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs4737	chr16:75238103-75238104	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
14	rs143963707	chr16:75238113-75238114	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs150936688	chr16:75238122-75238123	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs376020915	chr16:75238126-75238127	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs1049299	chr16:75238130-75238131	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs1049298	chr16:75238134-75238135	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs202142318	chr16:75238135-75238136	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs199561534	chr16:75238143-75238144	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs201069805	chr16:75238144-75238145	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs137960796	chr16:75238148-75238149	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs150266828	chr16:75238162-75238163	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs368315546	chr16:75238184-75238185	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs1049293	chr16:75238185-75238186	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs1130512	chr16:75238191-75238192	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs147088344	chr16:75238194-75238195	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs372637324	chr16:75238195-75238196	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs138352937	chr16:75238202-75238203	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs200914367	chr16:75238206-75238207	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs1130511	chr16:75238209-75238210	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs1130509	chr16:75238218-75238219	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs367685599	chr16:75238224-75238225	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs371932307	chr16:75238233-75238234	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs375207313	chr16:75238235-75238236	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs369340318	chr16:75238239-75238240	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs368123078	chr16:75238241-75238242	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs376670679	chr16:75238245-75238246	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs202120814	chr16:75238249-75238250	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs76251204	chr16:75238253-75238254	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs201577960	chr16:75238258-75238259	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs201493101	chr16:75238262-75238263	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs545187336	chr16:75238264-75238265	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs533062707	chr16:75238266-75238267	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs373115743	chr16:75238268-75238269	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs138409831	chr16:75238285-75238286	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs544950243	chr16:75238287-75238288	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs535078257	chr16:75238290-75238291	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs565520532	chr16:75238299-75238300	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs555318058	chr16:75238308-75238309	Enhancers Weak transcription Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Melanoma	22183965	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Poland''s syndrome	22110015	CNVD
Neuroblastoma	21899760	CNVD
Liver carcinoma	19366792	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	19156837	CNVD
Acute myeloid leukemia	17377590	CNVD
Breast cancer	20409316	CNVD
Hepatocellular carcinoma	16750200	CNVD
Epilepsy	20502679	CNVD

Chromatin state (count:37 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:75232600-75240400	Weak transcription	HSMMtube	muscle
2	chr16:75235000-75238800	Weak transcription	Skeletal Muscle Male	skeletal muscle
3	chr16:75235400-75240200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr16:75235400-75241800	Weak transcription	Fetal Muscle Leg	muscle
5	chr16:75235600-75240200	Weak transcription	GM12878-XiMat	blood
6	chr16:75237200-75238200	Enhancers	HUES6 Cell Line	embryonic stem cell
7	chr16:75237400-75238400	Bivalent Enhancer	HepG2	liver
8	chr16:75237600-75238400	Enhancers	H1 Cell Line	embryonic stem cell
9	chr16:75237600-75238600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr16:75237800-75238600	Transcr. at gene 5' and 3'	Pancreas	Pancrea
11	chr16:75238600-75240000	Weak transcription	Pancreas	Pancrea
12	chr16:75238600-75240400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr16:75240000-75240200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
14	chr16:75240000-75240200	Active TSS	Pancreas	Pancrea
15	chr16:75240000-75241200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
16	chr16:75240000-75241200	Active TSS	Pancreatic Islets	Pancreatic Islet
17	chr16:75240200-75240400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
18	chr16:75240200-75240600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
19	chr16:75240200-75241000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
20	chr16:75240200-75241000	Transcr. at gene 5' and 3'	Pancreas	Pancrea
21	chr16:75240200-75241000	Enhancers	GM12878-XiMat	blood
22	chr16:75240400-75240600	Bivalent/Poised TSS	Colon Smooth Muscle	Colon
23	chr16:75240400-75241000	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
24	chr16:75240400-75241000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
25	chr16:75240400-75241400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr16:75240400-75242200	Enhancers	Spleen	Spleen
27	chr16:75240400-75243200	Enhancers	HSMMtube	muscle
28	chr16:75240600-75240800	Bivalent Enhancer	Ovary	ovary
29	chr16:75240600-75241200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
30	chr16:75240600-75241400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
31	chr16:75240800-75241000	Enhancers	HSMM	muscle
32	chr16:75240800-75241800	Enhancers	Placenta	Placenta
33	chr16:75241000-75241200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
34	chr16:75241000-75241200	Active TSS	Pancreas	Pancrea
35	chr16:75241000-75241200	Bivalent Enhancer	HepG2	liver
36	chr16:75241000-75242000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr16:75241000-75242200	Weak transcription	HSMM	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links